A-SEEDS
Matsumoto, JP · 3 known investors
A-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments. The company focuses on advancing basic research through non-clinical development into clinical application of these cancer cell therapies.
Founders & leadership
YN
Yozo NakazawaFounder & Director; Professor, Department of Pediatrics, Shinshu University
SY
Shigeki YagyuRepresentative Director (CEO)
TA
Takuji AchihaChief Development Officer
KT
Kiyohito TaniChief Operating Officer
Investors · 3
Frequently asked questions
- What does A-SEEDS do?
- A-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments. The company focuses on advancing basic research through non-clinical development into clinical application of these cancer cell therapies.
- Who founded A-SEEDS?
- A-SEEDS was founded by Yozo Nakazawa.
- Who are A-SEEDS's investors?
- A-SEEDS's investors include Delight Ventures, Nippon Venture Capital, OSAKA University Venture Capital.
- Where is A-SEEDS headquartered?
- A-SEEDS is headquartered in Matsumoto, JP.